Page 1040 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHaPter 74 Immunological Ocular Disease 1003

11. Huang Y, Yang B, Li W. Defining the normal “core microbiome” of 32. Liu D, Birnbaum AD. Update on sarcoidosis. Curr Opin Ophthalmol
conjunctival microbial communities. Clin Microbiol Infect 2015;26:512–16.
2016;22:643.e7–12. 33. Pasadhika S, Rosenbaum JT. Ocular Sarcoidosis. Clin Chest Med
12. Lee AY, Akileswaran L, Tibbetts MD, et al. Identification of torque teno 2015;36:669–83.
virus in culture-negative endophthalmitis by representational deep DNA 34. Kotter I, Zierhut M, Eckstein AK, et al. Human recombinant interferon
sequencing. Ophthalmology 2015;122:524–30. alfa-2a for the treatment of Behcet’s disease with sight threatening
13. Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis posterior or panuveitis. Br J Ophthalmol 2003;87:423–31.
Nomenclature Working G. Standardization of uveitis nomenclature for 35. Van Staa TP, Leufkens HGM, Abenhaim L, et al. Use of oral
reporting clinical data. Results of the First International Workshop. Am J corticosteroids and risk of fractures. J Bone Miner Res 2000;15:
Ophthalmol 2005;140:509–16. 993–1000.
14. Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern 36. Messenger W, Hildebrandt L, Mackensen F, et al. Characterisation of
California; the Northern California Epidemiology of Uveitis Study. uveitis in association with multiple sclerosis. Br J Ophthalmol
Ophthalmology 2004;111:491–500, discussion 500. 2015;99:205–9.
15. Rosenbaum JT. An algorithm for the systemic evaluation of patients with 37. Edelsten C, Lee V, Bentley CR, et al. An evaluation of baseline risk factors
uveitis: guidelines for the consultant. Semin Arthritis Rheum predicting severity in juvenile idiopathic arthritis associated uveitis and
1990;19:248–57. other chronic anterior uveitis in early childhood. Br J Ophthalmol
16. Dick AD, Tugal-Tutkun I, Foster S, et al. Secukinumab in the treatment of 2002;86:51–6.
noninfectious uveitis: results of three randomized, controlled clinical 38. Simonini G, Taddio A, Cattalini M, et al. Prevention of flare
trials. Ophthalmology 2013;120:777–87. recurrences in childhood-refractory chronic uveitis: an open-label
17. Nguyen QD, Merrill PT, Jaffe GJ, et al. Adalimumab for prevention of comparative study of adalimumab versus infliximab. Arthritis Care Res
uveitic flare in patients with inactive non-infectious uveitis controlled by 2011;63:612–18.
corticosteroids (VISUAL II): a multicentre, double-masked, randomised, 39. Raiji VR, Palestine AG, Parver DL. Scleritis and systemic disease
placebo-controlled phase 3 trial. Lancet 2016;388:1183–92. association in a community-based referral practice. Am J Ophthalmol
18. Jaffe GJ, Dick AD, Brezin AP, et al. Adalimumab in Patients with Active 2009;148:946–50.
Noninfectious Uveitis. N Engl J Med 2016;375:932–43. 40. Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol
19. Suhler EB, Smith JR, Giles TR, et al. Infliximab therapy for refractory 1976;60:163–91.
uveitis: 2-year results of a prospective trial. Arch Ophthalmol 41. Riono WP, Hidayat AA, Rao NA. Scleritis: a clinicopathologic study of 55
2009;127:819–22. cases. Ophthalmology 1999;106:1328–33.
20. Brewerton DA, Caffrey M, Nicholls A, et al. Acute anterior uveitis and 42. Suhler EB, Lim LL, Beardsley RM, et al. Rituximab therapy for refractory
HL-A 27. Lancet 1973;302:994–6. scleritis: results of a phase I/II dose-ranging, randomized, clinical trial.
21. Rosenbaum JT. Acute anterior uveitis and spondyloarthropathies. Rheum Ophthalmology 2014;121:1885–91.
Dis Clin North Am 1992;18:143–51. 43. Albini TA, Zamir E, Read RW, et al. Evaluation of subconjunctival
22. Munoz-Fernandez S, Hidalgo V, Fernandez-Melon J, et al. Sulfasalazine triamcinolone for nonnecrotizing anterior scleritis. Ophthalmology
reduces the number of flares of acute anterior uveitis over a one-year 2005;112:1814–20.
period. J Rheumatol 2003;30:1277–9. 44. Sainz de la Maza MF, Foster CS, Jabbur NS. Scleritis associated with
23. Braun J, Baraliakos X, Listing J, et al. Decreased incidence of anterior rheumatoid arthritis and with other systemic immune mediated diseases.
uveitis in patients with ankylosing spondylitis treated with the anti-tumor Ophthalmology 1994;101:1281–6.
necrosis factor agents infliximab and etanercept. Arthritis Rheum 45. Hoang LT, Lim LL, Vaillant B, et al. Antineutrophil cytoplasmic
2005;52:2447–51. antibody-associated active scleritis. Arch Ophthalmol 2008;126:651–5.
24. Haroon M, O’Rourke M, Ramasamy P, et al. A novel evidence-based 46. Lin P, Bhullar SS, Tessler HH, et al. Immunologic markers as potential
detection of undiagnosed spondyloarthritis in patients presenting with predictors of systemic autoimmune disease in patients with idiopathic
acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool). Ann scleritis. Am J Ophthalmol 2008;145:463–71.
Rheum Dis 2015;74:1990–5. 47. Cogan DG. Syndrome of nonsyphilitic interstitial keratitis and
25. Rudwaleit M, van der Heijde D, Landewe R, et al. The Assessment of vestibuloauditory symptoms. Arch Ophthalmol 1945;33:144–9.
SpondyloArthritis International Society classification criteria for 48. Liu S, Veldman P. Evidence-based endothelial rehabilitation. Semin
peripheral spondyloarthritis and for spondyloarthritis in general. Ann Ophthalmol 2017;32:96–103.
Rheum Dis 2011;70:25–31. 49. Weleber RG, Watzke RC, Shults WT, et al. Clinical and electrophysiologic
26. Juanola X, Loza Santamaria E, Cordero-Coma M, et al. Description and characterization of paraneoplastic and autoimmune retinopathies
Prevalence of Spondyloarthritis in Patients with Anterior Uveitis: The associates with antienolase antibodies. Am J Ophthalmol
SENTINEL Interdisciplinary Collaborative Project. Ophthalmology 2005;139:780–94.
2016;123:1632–6. 50. Thirkill CE, Keltner JL, Tyler NK, et al. Antibody reactions with retina
27. Salmon JF, Wright JP, Murray AD. Ocular inflammation in Crohn’s and cancer-associated antigens in 10 patients with cancer-associated
disease. Ophthalmology 1991;98:480–4. retinopathy. Arch Ophthalmol 1993;111:931–7.
28. Lyons JL, Rosenbaum JT. Uveitis associated with inflammatory bowel 51. Ferreyra HA, Jayasundera T, Khan NW, et al. Management of
disease compared with uveitis associated with spondyloarthropathy. Arch autoimmune retinopathies with immunosuppression. Arch Ophthalmol
Ophthalmol 1997;115:61–4. 2009;127:390–7.
29. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis 52. Hughes AE, Bridgett S, Meng W, et al. Sequence and expression of
in people with psoriasis. Arthritis Rheum 2009;61:1373–8. complement factor H gene cluster variants and their roles in
30. James DG. Ocular sarcoidosis. Ann N Y Acad Sci 1986;465:551–63. age-related macular degeneration risk. Invest Ophthalmol Vis Sci
31. Kosmorsky GS, Meisler DM, Rice TW, et al. Chest computed tomography 2016;57:2763–9.
and mediastinoscopy in the diagnosis of sarcoidosis-associated uveitis.
Am J Ophthalmol 1998;126:132–4.